- 12/8/11 •
NanoString Technologies Announces Positive Results from First Validation Study of PAM50-based Breast Cancer Assay
- 11/07/11 •
NanoString Secures $20M in Series D Financing
- 10/12/2011 •
NanoString Announces Launch of Second Generation nCounter Analysis System
- 09/21/2011 •
NanoString Introduces Solution for Simultaneously Measuring miRNA and mRNA Expression Levels
- 08/05/2011 •
NanoString Introduces Rat miRNA Expression Assays
- 08/03/2011 •
NanoString Embarks on First in Series of Clinical Studies for Breast Cancer Intrinsic Subtyping Assay
- 10/21/2011 •
The NEW nSolver Analysis Software is now available and free of charge to nCounter users
- 10/12/11 •
The NEW GEN2 nCounter System is now available.
- 9/20/2011 •
miRGE CodeSets are now available
- 8/5/2011 •
The nCounter Rat microRNA Expression Assay is now available
- 7/28/11 •
NanoString launches new assay kit for characterization of leukemia fusion genes and biomarkers
- 7/22/11 •
Click to watch: Univ. of Geneva and NanoString: Tracking Genetic Clues
- 02/22/2011 •
The nCounter Human Karyotype Panel is now available.












